繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

STAAR外科授权5000万美元股票回购

2026-09-25 04:05

  • STAAR Surgical’s (STAA) board authorized a share repurchase program of up to $50M of its outstanding common stock.
  • The program is expected to run for 12 months.
  • STAAR plans to fund repurchases with organic free cash flow and cash on hand, with no outstanding debt and $181.5M in cash, equivalents, and investments as of July 3, 2026.
  • The company had ~50.1M shares outstanding as of August 7, 2026, making the authorized buyback equivalent to up to roughly 5% of shares outstanding if fully utilized.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。